Désolé, cet article est seulement disponible en anglais américain.
Cliquez pour voir le graph
Connexions
Membres
Didier Ménard
Responsable de Structure
Responsable
Projets
Projet Transversal
Financements
Publications
Télécharger-
2022Human peroxiredoxin 6 is essential for malaria parasites and provides a host-based drug target., Cell Rep 2022 Jun; 39(11): 110923.
-
2021Compensating P. falciparum artemisinin resistance., Cell Host Microbe 2021 Dec; 29(12): 1732-1734.
-
2021Compensating P. falciparum artemisinin resistance, Cell Host & Microbe.
-
2021Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria., Malar J 2021 Sep; 20(1): 366.
-
2021Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria., PLoS Negl Trop Dis 2021 Sep; 15(9): e0009690.
-
2021A genetic intervention., Elife 2021 Aug; 10(): .
-
2021Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness., Elife 2021 Jul; 10(): .
-
2021Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea., Malar J 2021 Jun; 20(1): 275.
-
2021Genetic diversity of Plasmodium falciparum populations in three malaria transmission settings in Madagascar., Malar J 2021 May; 20(1): 239.
-
2021Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017-2018., Malar J 2021 Jan; 20(1): 48.
-
+Voir la liste complète de publications